Compounds > adenosine
Page last updated: 2024-08-24

adenosine and Bone Cancer

adenosine has been researched along with Bone Cancer in 19 studies

Research

Studies (19)

TimeframeStudies, this research(%)All Research%
pre-19901 (5.26)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's6 (31.58)24.3611
2020's12 (63.16)2.80

Authors

AuthorsStudies
Quan, H; Wang, J; Xu, K; Zhang, J; Zhang, P1
Chen, Y; He, J; Lin, H; Miao, L; Zhuo, Z1
Gao, Y; Qu, YX; Wang, B; Wei, K1
Chen, HL; Duan, G; Gu, WX; Shan, HJ1
Bao, X; Cai, Z; Luo, Z; Yang, C; Yang, Z1
Chen, S; Deng, Y; Hu, M; Huang, L; Jing, S; Li, J; Li, Y; Liu, T; Miao, J; Peng, Y; Wang, D; Wang, S; Wang, W; Xu, D; Yan, Z; Yu, H; Zeng, J; Zhang, A; Zhao, X; Zhou, Z1
Han, J; Kong, H; Wang, X; Zhang, XA1
Cheng, ZJ; Huang, SY; Kawaguchi, T; Li, HF; Liang, B; Ni, JS; Samant, H; Tao, YP; Wang, ZG; Wu, J; Xiang, DM; Yang, L; Yang, Y; Yuan, SX; Zheng, H; Zhou, WP1
Bao, Y; Chen, B; He, M; Lu, J; Luo, Y; Qiu, G; Wang, Y; Xu, J; Xu, Y; Zhang, Y1
Adouane, D; Aury-Landas, J; Baugé, C; Boumediene, K; Delépée, R; Girard, N; Lhuissier, E1
Dong, Y; Ji, W; Liang, C; Tu, S; Wang, Y; Wei, Y; Zan, R; Zeng, L; Zhang, Z1
Chen, L; Ling, Z; Zhao, J1
Niu, Y; Wei, Y; Wen, S; Xiong, W; Zen, C; Zhao, Y1
Dai, Y; Du, H; Lang, C; Li, Y; Lin, K; Peng, X; Ren, D; Wu, Z; Yang, Q; Yin, C1
Chen, J; Jia, L; Ma, J; Miao, W; Song, D1
Bezuhly, M; Gebremeskel, S; Johnston, B; LeVatte, T; Liwski, RS1
Ellies, LG; Gao, X; Jiang, JX; Riquelme, MA; Sun, LZ; Zhou, JZ1
Clemens, D; Dirksen, U; Hotfilder, M; Klco-Brosius, S; Pettke, A; Potratz, J; Schaefer, C1
Nozue, AT; Ono, S1

Reviews

3 review(s) available for adenosine and Bone Cancer

ArticleYear
The role of m6A modification in pediatric cancer.
    Biochimica et biophysica acta. Reviews on cancer, 2022, Volume: 1877, Issue:2

    Topics: Adenosine; Bone Neoplasms; Child; Epigenesis, Genetic; Humans; Osteosarcoma; RNA, Messenger

2022
Novel insights into the interaction between N6-methyladenosine methylation and noncoding RNAs in musculoskeletal disorders.
    Cell proliferation, 2022, Volume: 55, Issue:10

    Topics: Adenosine; Bone Neoplasms; Humans; Intervertebral Disc Degeneration; Methylation; MicroRNAs; Osteoarthritis; Osteoporosis; Osteosarcoma; RNA, Circular; RNA, Long Noncoding; RNA, Untranslated

2022
N6-methyladenosine (m6A) modification in osteosarcoma: expression, function and interaction with noncoding RNAs - an updated review.
    Epigenetics, 2023, Volume: 18, Issue:1

    Topics: Adenosine; Adolescent; Bone Neoplasms; Child; DNA Methylation; Humans; MicroRNAs; Osteosarcoma; RNA, Untranslated; Tumor Microenvironment

2023

Other Studies

16 other study(ies) available for adenosine and Bone Cancer

ArticleYear
Identification of N6-methylandenosine related LncRNAs biomarkers associated with the overall survival of osteosarcoma.
    BMC cancer, 2021, Dec-01, Volume: 21, Issue:1

    Topics: Adenosine; Biomarkers, Tumor; Bone and Bones; Bone Neoplasms; Humans; Osteosarcoma; Proportional Hazards Models; Risk Factors; RNA, Long Noncoding; Survival Rate; Up-Regulation

2021
Methylation recognition protein YTH N6-methyladenosine RNA binding protein 1 (YTHDF1) regulates the proliferation, migration and invasion of osteosarcoma by regulating m6A level of CCR4-NOT transcription complex subunit 7 (CNOT7).
    Bioengineered, 2022, Volume: 13, Issue:3

    Topics: Adenosine; Bone Neoplasms; Cell Proliferation; Exoribonucleases; Humans; Methylation; Methyltransferases; Osteosarcoma; Receptors, CCR4; Repressor Proteins; RNA-Binding Proteins; RNA, Messenger

2022
Fat mass and obesity associated (FTO)-mediated N6-methyladenosine modification of Krüppel-like factor 3 (KLF3) promotes osteosarcoma progression.
    Bioengineered, 2022, Volume: 13, Issue:4

    Topics: Adenosine; Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Bone Neoplasms; Humans; Kruppel-Like Transcription Factors; Osteosarcoma; RNA, Messenger

2022
ALKBH5 regulates STAT3 activity to affect the proliferation and tumorigenicity of osteosarcoma via an m6A-YTHDF2-dependent manner.
    EBioMedicine, 2022, Volume: 80

    Topics: Adenosine; AlkB Homolog 5, RNA Demethylase; Bone Neoplasms; Cell Proliferation; Humans; Osteosarcoma; RNA; RNA-Binding Proteins; RNA, Messenger; STAT3 Transcription Factor

2022
RNA adenosine modifications related to prognosis and immune infiltration in osteosarcoma.
    Journal of translational medicine, 2022, 05-14, Volume: 20, Issue:1

    Topics: Adenosine; Biomarkers, Tumor; Bone Neoplasms; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Humans; Osteosarcoma; Prognosis; RNA; Strophanthidin

2022
N
    International journal of biological sciences, 2023, Volume: 19, Issue:4

    Topics: Adenosine; Bone Neoplasms; Carcinoma, Hepatocellular; Carrier Proteins; Humans; Liver Neoplasms; Methyltransferases; Tumor Microenvironment

2023
The Antitumoral Effect of the S-Adenosylhomocysteine Hydrolase Inhibitor, 3-Deazaneplanocin A, is Independent of EZH2 but is Correlated with EGFR Downregulation in Chondrosarcomas.
    Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2019, Volume: 53, Issue:4

    Topics: Adenosine; Animals; Apoptosis; Bone Neoplasms; Cell Line, Tumor; Cell Survival; Chondrosarcoma; DNA Damage; Down-Regulation; Enhancer of Zeste Homolog 2 Protein; ErbB Receptors; Histones; Humans; Male; Mice; Mice, Nude; Protein Interaction Maps; RNA Interference; RNA, Small Interfering; S-Adenosylhomocysteine

2019
Integrated analysis of transcriptome-wide m
    Epigenomics, 2019, 11-01, Volume: 11, Issue:15

    Topics: Adenosine; Bone Neoplasms; Cell Line, Tumor; Epigenesis, Genetic; Epigenome; Gene Expression Profiling; Humans; Methylation; Neoplastic Stem Cells; Osteosarcoma; RNA; Transcriptome

2019
m6A-dependent up-regulation of DRG1 by METTL3 and ELAVL1 promotes growth, migration, and colony formation in osteosarcoma.
    Bioscience reports, 2020, 04-30, Volume: 40, Issue:4

    Topics: Adenosine; Bone and Bones; Bone Neoplasms; Cell Line, Tumor; Computational Biology; DNA Methylation; ELAV-Like Protein 1; Epigenesis, Genetic; Female; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; GTP-Binding Proteins; Humans; Male; Methyltransferases; Osteosarcoma; Up-Regulation; Young Adult

2020
Long non-coding RNA NEAT1 promotes bone metastasis of prostate cancer through N6-methyladenosine.
    Molecular cancer, 2020, 12-12, Volume: 19, Issue:1

    Topics: Adenosine; Aged; Aged, 80 and over; Animals; Bone Neoplasms; Cell Line, Tumor; Core Binding Factor Alpha 1 Subunit; Cyclin-Dependent Kinases; Cyclins; Humans; Male; Mice, Nude; Middle Aged; Phosphorylation; Phosphoserine; Prognosis; Promoter Regions, Genetic; Prostatic Neoplasms; RNA Polymerase II; RNA, Long Noncoding

2020
m
    Clinical and translational medicine, 2021, Volume: 11, Issue:6

    Topics: Adenosine; Animals; Apoptosis; Biomarkers, Tumor; Bone Neoplasms; Cell Cycle; Cell Movement; Cell Proliferation; Gene Expression Regulation, Neoplastic; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Prognosis; Prostatic Neoplasms; Receptor, IGF Type 1; RNA Stability; RNA-Binding Proteins; RNA, Long Noncoding; Survival Rate; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2021
The m6A methyltransferase METTL3 promotes osteosarcoma progression by regulating the m6A level of LEF1.
    Biochemical and biophysical research communications, 2019, 08-27, Volume: 516, Issue:3

    Topics: Adenosine; Adolescent; Bone Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Child; Disease Progression; Humans; Lymphoid Enhancer-Binding Factor 1; Methylation; Methyltransferases; Osteosarcoma; RNA Interference; RNA, Messenger; Wnt Signaling Pathway

2019
The reversible P2Y12 inhibitor ticagrelor inhibits metastasis and improves survival in mouse models of cancer.
    International journal of cancer, 2015, Jan-01, Volume: 136, Issue:1

    Topics: Adenosine; Animals; Antineoplastic Agents; Bone Neoplasms; Drug Screening Assays, Antitumor; Female; Gene Expression; Liver Neoplasms; Lung Neoplasms; Mammary Neoplasms, Experimental; Melanoma, Experimental; Mice, Inbred BALB C; Mice, Inbred C57BL; Neoplasm Transplantation; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y12; Ticagrelor

2015
Differential impact of adenosine nucleotides released by osteocytes on breast cancer growth and bone metastasis.
    Oncogene, 2015, Apr-02, Volume: 34, Issue:14

    Topics: Adenosine; Adenosine Triphosphate; Alendronate; Animals; Apyrase; Bone Density Conservation Agents; Bone Neoplasms; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Female; Humans; Mice; Mice, Inbred C57BL; Mice, Nude; Neoplasm Transplantation; Osteocytes; Receptor, Adenosine A2A; Receptors, Purinergic P2X; RNA Interference; RNA, Small Interfering; Signal Transduction; Transplantation, Heterologous

2015
Suberanilohydroxamic acid (vorinostat) synergistically enhances the cytotoxicity of doxorubicin and cisplatin in osteosarcoma cell lines.
    Anti-cancer drugs, 2016, Volume: 27, Issue:10

    Topics: Adenosine; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Bone Neoplasms; Cell Growth Processes; Cell Line, Tumor; Cisplatin; Doxorubicin; Drug Synergism; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Osteosarcoma; Vorinostat

2016
Exposure of newborn mice to adenosine causes neural crest dysplasia and tumor formation.
    Neurofibromatosis, 1989, Volume: 2, Issue:5-6

    Topics: Adenosine; Adrenal Gland Neoplasms; Animals; Animals, Newborn; Bone Neoplasms; Carotid Body Tumor; Digestive System Neoplasms; Melanins; Melanoma; Mice; Mice, Inbred ICR; Muscular Diseases; Neoplasms, Experimental; Nervous System Neoplasms; Neural Crest; Neurofibroma; Peripheral Nervous System Neoplasms; Pheochromocytoma; Pigmentation Disorders; Skin Neoplasms; Tongue Neoplasms

1989